Published in Medicine and Law Weekly, June 30th, 2006
The trial court judge had ruled that Boston Scientific's TAXUS Express, Express, and NIR stents do not infringe four Medtronic stent patents. Medtronic had filed an appeal of the trial court decisions. In upholding the trial court, the Court of Appeals agreed that Boston Scientific's products were not within the scope of the Medtronic patents.
"We are very pleased that the Court of Appeals has ruled that Boston Scientific does not infringe," said Paul...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly